Рецепт. 2018; : 863-871
Лечение реактивного хламидиоиндуцированного артрита при беременности
Аннотация
Статья посвящена вопросам лечения беременных с реактивным хламидиоиндуцированным артритом, подбора антибактериальных препаратов, нестероидных противовоспалительных, глюкокортикоидных и длительно действующих средств. Сложностью представляется ведение пациенток в разных триместрах беременности, что требует совместной работы гинекологов и ревматологов.
Список литературы
1. Carter J.D., Gerard H.C., Whittum-Hudson J.A. et al. (2011) Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight? Int J Clin Rheumatol, no 6 (3), pp. 333-345.
2. Braun J.et al. 2000 On the difficulties of definition and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th international Workshop on Reactive Arthritis, Berlin, July 3-6, 1999. Rheumatology, no 27 (9), pp. 2185-2192.
3. Centers for Disease Control and Prevention. Sexually Transmitted Diseases. Treatment Guidelines 2006. MMWR 2006; 55, no RR-11.
4. Moss T.R. (2006) International Handbook of Chlamydia. 2nd Edition. Euromed Communications Ltd, UK, р. 205.
5. Hryanin A.A., Reshetnikov O.V., Krivenchuk N.A., Guschin A.E., Alaeva O.A. (2006) Hlamidioz u zhenschin: sopostavlenie raznih metodov diagnostiki, faktori riska i klinicheskie proyavleniya [Women Chlamidia infection: comparison of different diagnostic methods, risk factors and clinical manifestations]. Vestn. dermatol, no 2, pp. 40-43.
6. Hryanin A.A., Reshetnikov O.V. (2008) Makrolidi v lechenii hlamidiinoi infektsii u beremennih (effektivnost’, ekonomichnost’, bezopasnost’) [Macrolides in treatment of Chlamidia infection in pregnancy (efficacy, cost effectiveness, safety)]. RMZh, vol.16, no 3.
7. Miller J.M., Martin D.H. (2000) Treatment of Chlamydia trachomatis infections in pregnant women. Drugs, no 60 (3), pp. 597-605.
8. Habrieva R.U., Chuchalina A.G. (2005) Lekarstvennie sredstva [Medicinal products]. No 2.
9. Majeroni B.A, Ukkadam S. (2007) Screening and treatment for sexually transmitted infections in pregnancy. Am Fam Physician, no 76, pp. 265-270.
10. Kallen B., Otterblad Olausson P., Danielsson B. (2005) Is erythromycin therapy teratogenic in humans? Reprod. Toxicol, no 20, pp. 209-214.
11. Kubanova A.A. (2003) Metodicheskie materiali po diagnostike i lecheniyu naibolee rasprostranennih infektsii, peredavaemih polovim putem (IPPP), i zabolevanii kozhi [Methodical material on diagnostics and treatment of the most common sexually transmitted infections (STI), and skin diseases]. M.: GEOTAR-MED. (in Russian)
12. Gosudarstvennii Reestr Lekarstvennih Sredsstv RF. Dzhozamitsin. Tipovaya kliniko- farmakologicheskaya stat’ya. 2009 g. [State register of medicines, the Russian Federation. Josamycin. Typical clinical and pharmacological article. 2009].
13. Dzhozamitsin. Registr lekarstvennih sredstv Rossii (RLS), 2008 g. [Josamycin. Russian register of medicines. 2008].
14. Charles P., Stumpf P., Buffet P. et al. (2008) Two unusual glandular presentations of tick-borne tularemia. Med. Mal. Infect, no 38 (3), pp. 159-161.
15. Reshetnikov O.V., Hryanin A.A. (2008) Makrolidi v lechenii hlamidiinoi infektsii u beremennih (effektivnost’, bezopasnost’, ekonomichnost’) [Macrolides in treatment of Chlamidia infection in pregnancy (efficacy, cost effectiveness, safety)]. RMZh, no 16 (1), pp. 23-27.
16. Ramsey P., Vaules M., Vasdev G.M. et al. (2003) Maternal and transplacental pharmacokinetics of azithromycin. Am. J. Obstet. Gynecol., no 188 (3), pp. 714-718.
17. Sarkar M., Woodland C., Koren G. et al. (2006) Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth., no 6, p. 18.
18. Rahangdale L., Guerry S., Bauer H. et al. (2006) An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sex. Transm. Dis., no 33, pp. 106-110.
19. Pitsouni E., Iavazzo C., Athanasiou S., Falagas M.E. (2007) Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta- analysis of randomised controlled trials. Int. J. Antimicrob. Agents., no 30 (3), pp. 213-221.
20. Varon’ko I.A. (2017) Reaktivnie hlamidioindutsirovannie artropatii: klinicheskie formi, differentsirovannaya terapiya [Reactive Chlamidia-induced arthropathies: clinical forms, differentiated therapy]. Retsept, vol. 20, no 3, pp. 383-400.
21. Burbello A.T., Shabrov A.V. (2011) Noveishaya entsiklopediya sovremennih lekarstv [The new encyclopedia of modern medicines]. M.: OLMA Media Group.
22. Nasonova E.L., Nasonovoi V.A. (2008) Revmatologiya: natsional’noe rukovodstvo [Rheumatology: national guidelines]. M.: GEOTAR-Media.
23. Henry C.H. et al. (2007) Reactive arthritis and internal derangement of the temporomandibular joint arthritis. Oral. Surg. Oral. Med. Oral Pathol. Oral Radiol. Endod, vol. 104, no 1, pp. 22-26.
Recipe. 2018; : 863-871
Treatment of reactive chlamidiа-induced arthritis in pregnancy
Abstract
References
1. Carter J.D., Gerard H.C., Whittum-Hudson J.A. et al. (2011) Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight? Int J Clin Rheumatol, no 6 (3), pp. 333-345.
2. Braun J.et al. 2000 On the difficulties of definition and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th international Workshop on Reactive Arthritis, Berlin, July 3-6, 1999. Rheumatology, no 27 (9), pp. 2185-2192.
3. Centers for Disease Control and Prevention. Sexually Transmitted Diseases. Treatment Guidelines 2006. MMWR 2006; 55, no RR-11.
4. Moss T.R. (2006) International Handbook of Chlamydia. 2nd Edition. Euromed Communications Ltd, UK, r. 205.
5. Hryanin A.A., Reshetnikov O.V., Krivenchuk N.A., Guschin A.E., Alaeva O.A. (2006) Hlamidioz u zhenschin: sopostavlenie raznih metodov diagnostiki, faktori riska i klinicheskie proyavleniya [Women Chlamidia infection: comparison of different diagnostic methods, risk factors and clinical manifestations]. Vestn. dermatol, no 2, pp. 40-43.
6. Hryanin A.A., Reshetnikov O.V. (2008) Makrolidi v lechenii hlamidiinoi infektsii u beremennih (effektivnost’, ekonomichnost’, bezopasnost’) [Macrolides in treatment of Chlamidia infection in pregnancy (efficacy, cost effectiveness, safety)]. RMZh, vol.16, no 3.
7. Miller J.M., Martin D.H. (2000) Treatment of Chlamydia trachomatis infections in pregnant women. Drugs, no 60 (3), pp. 597-605.
8. Habrieva R.U., Chuchalina A.G. (2005) Lekarstvennie sredstva [Medicinal products]. No 2.
9. Majeroni B.A, Ukkadam S. (2007) Screening and treatment for sexually transmitted infections in pregnancy. Am Fam Physician, no 76, pp. 265-270.
10. Kallen B., Otterblad Olausson P., Danielsson B. (2005) Is erythromycin therapy teratogenic in humans? Reprod. Toxicol, no 20, pp. 209-214.
11. Kubanova A.A. (2003) Metodicheskie materiali po diagnostike i lecheniyu naibolee rasprostranennih infektsii, peredavaemih polovim putem (IPPP), i zabolevanii kozhi [Methodical material on diagnostics and treatment of the most common sexually transmitted infections (STI), and skin diseases]. M.: GEOTAR-MED. (in Russian)
12. Gosudarstvennii Reestr Lekarstvennih Sredsstv RF. Dzhozamitsin. Tipovaya kliniko- farmakologicheskaya stat’ya. 2009 g. [State register of medicines, the Russian Federation. Josamycin. Typical clinical and pharmacological article. 2009].
13. Dzhozamitsin. Registr lekarstvennih sredstv Rossii (RLS), 2008 g. [Josamycin. Russian register of medicines. 2008].
14. Charles P., Stumpf P., Buffet P. et al. (2008) Two unusual glandular presentations of tick-borne tularemia. Med. Mal. Infect, no 38 (3), pp. 159-161.
15. Reshetnikov O.V., Hryanin A.A. (2008) Makrolidi v lechenii hlamidiinoi infektsii u beremennih (effektivnost’, bezopasnost’, ekonomichnost’) [Macrolides in treatment of Chlamidia infection in pregnancy (efficacy, cost effectiveness, safety)]. RMZh, no 16 (1), pp. 23-27.
16. Ramsey P., Vaules M., Vasdev G.M. et al. (2003) Maternal and transplacental pharmacokinetics of azithromycin. Am. J. Obstet. Gynecol., no 188 (3), pp. 714-718.
17. Sarkar M., Woodland C., Koren G. et al. (2006) Pregnancy outcome following gestational exposure to azithromycin. BMC Pregnancy Childbirth., no 6, p. 18.
18. Rahangdale L., Guerry S., Bauer H. et al. (2006) An observational cohort study of Chlamydia trachomatis treatment in pregnancy. Sex. Transm. Dis., no 33, pp. 106-110.
19. Pitsouni E., Iavazzo C., Athanasiou S., Falagas M.E. (2007) Single-dose azithromycin versus erythromycin or amoxicillin for Chlamydia trachomatis infection during pregnancy: a meta- analysis of randomised controlled trials. Int. J. Antimicrob. Agents., no 30 (3), pp. 213-221.
20. Varon’ko I.A. (2017) Reaktivnie hlamidioindutsirovannie artropatii: klinicheskie formi, differentsirovannaya terapiya [Reactive Chlamidia-induced arthropathies: clinical forms, differentiated therapy]. Retsept, vol. 20, no 3, pp. 383-400.
21. Burbello A.T., Shabrov A.V. (2011) Noveishaya entsiklopediya sovremennih lekarstv [The new encyclopedia of modern medicines]. M.: OLMA Media Group.
22. Nasonova E.L., Nasonovoi V.A. (2008) Revmatologiya: natsional’noe rukovodstvo [Rheumatology: national guidelines]. M.: GEOTAR-Media.
23. Henry C.H. et al. (2007) Reactive arthritis and internal derangement of the temporomandibular joint arthritis. Oral. Surg. Oral. Med. Oral Pathol. Oral Radiol. Endod, vol. 104, no 1, pp. 22-26.
